Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1978 1
1979 1
1981 2
1982 1
1984 4
1985 6
1986 6
1987 7
1988 5
1989 12
1990 13
1991 9
1992 9
1993 10
1994 11
1995 18
1996 12
1997 21
1998 10
1999 11
2000 10
2001 9
2002 6
2003 6
2004 8
2005 9
2006 8
2007 8
2008 8
2009 6
2010 8
2011 7
2012 4
2013 9
2014 9
2015 6
2016 5
2017 29
2018 36
2019 38
2020 47
2021 33
2022 34
2023 34
2024 4

Text availability

Article attribute

Article type

Publication date

PubMed for id: 116109

500 results

Results by year

Filters applied: . Clear all
Page 1
A cerebral lymphoma mimicking a meningioma: case report.
Joudar I, Nasri S, Aichouni N, Kamaoui I, Skiker I. Joudar I, et al. Ann Med Surg (Lond). 2023 Aug 4;85(10):5100-5104. doi: 10.1097/MS9.0000000000001126. eCollection 2023 Oct. Ann Med Surg (Lond). 2023. PMID: 37811052 Free PMC article.
Incidental Finding of a Large Right Atrial Thrombus in a Patient With Cerebral Lymphoma.
Fath AR, Eldaly AS, Aglan A, Varkoly KS, Beladi RN, Solsi A, Hahn MF, Karis JP, Nafisi S, Brady K, Bellamkonda P, Wakefield DN, Clapp WL, Lucas AR. Fath AR, et al. J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211001636. doi: 10.1177/23247096211001636. J Investig Med High Impact Case Rep. 2021. PMID: 33749363 Free PMC article.
Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network.
Soussain C, Choquet S, Blonski M, Leclercq D, Houillier C, Rezai K, Bijou F, Houot R, Boyle E, Gressin R, Nicolas-Virelizier E, Barrie M, Moluçon-Chabrot C, Lelez ML, Clavert A, Coisy S, Leruez S, Touitou V, Cassoux N, Daniau M, Ertault de la Bretonnière M, El Yamani A, Ghesquières H, Hoang-Xuan K. Soussain C, et al. Eur J Cancer. 2019 Aug;117:121-130. doi: 10.1016/j.ejca.2019.05.024. Epub 2019 Jul 3. Eur J Cancer. 2019. PMID: 31279304 Clinical Trial.
Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective 'proof of concept' phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)†.
Ghesquieres H, Chevrier M, Laadhari M, Chinot O, Choquet S, Moluçon-Chabrot C, Beauchesne P, Gressin R, Morschhauser F, Schmitt A, Gyan E, Hoang-Xuan K, Nicolas-Virelizier E, Cassoux N, Touitou V, Le Garff-Tavernier M, Savignoni A, Turbiez I, Soumelis V, Houillier C, Soussain C. Ghesquieres H, et al. Ann Oncol. 2019 Apr 1;30(4):621-628. doi: 10.1093/annonc/mdz032. Ann Oncol. 2019. PMID: 30698644 Free article. Clinical Trial.
Fluorescein sodium-guided surgery in cerebral lymphoma.
Schebesch KM, Hoehne J, Hohenberger C, Acerbi F, Broggi M, Proescholdt M, Wendl C, Riemenschneider MJ, Brawanski A. Schebesch KM, et al. Clin Neurol Neurosurg. 2015 Dec;139:125-8. doi: 10.1016/j.clineuro.2015.09.015. Epub 2015 Sep 26. Clin Neurol Neurosurg. 2015. PMID: 26432995
500 results